Intercure Ltd. Ordinary Shares earnings per share and revenue
On Feb 19, 2026, INCR reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of 0.20 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 109.14 million, with a --% difference.
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Cytosorbents Corp.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.09
Surprise
-76.47%
Nephros Inc.
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.01
Actual
$0.08
Surprise
+684.31%
Capricor Therapeutics Inc
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.62
Surprise
-12.56%
Kestra Medical Technologies, Ltd. Common Stock
Report Date
Mar 17, 2026 For Q3 26
Estimate
-$0.60
Actual
-$0.61
Surprise
-0.39%
Sundial Growers Inc. Common Shares
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.01
Actual
$0.04
Surprise
+499.62%
High Tide Inc. Common Shares
Report Date
Mar 17, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+447.68%
Sanara MedTech Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.11
Actual
$0.04
Surprise
-64.35%
FAQ
What were Intercure Ltd. Ordinary Shares's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Intercure Ltd. Ordinary Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Intercure Ltd. Ordinary Shares's Q4 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Intercure Ltd. Ordinary Shares expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Intercure Ltd. Ordinary Shares's next earnings report?
Based on --
analysts, Intercure Ltd. Ordinary Shares is expected to report EPS of -- and revenue of -- for Q-- --.